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Abstract
The use of modified live virus (MLV) vaccines is a common procedure to control porcine reproductive and respira-
tory syndrome virus (PRRSV) infection in the great majority of countries from America, Asia and Europe, including 
Spain. Current discriminatory techniques allow the detection of different MLV type-II vaccine strains. Herein we report 
a rapid and accurate technique aimed to discriminate between MLV type-I vaccine strains and Spanish field strains. 
This technique comprises a reverse transcription (RT) and nested polymerase chain reaction (nPCR) amplification of 
PRRSV ORF5 followed by a digestion of RT-nPCR products with two specific endonucleases, ItaI and AccI. Combined 
utilization of ItaI and AccI generates restriction fragments length polymorphisms (RFLP) patterns adequate for the 
differentiation of 30 Spanish field isolates, of which 12 were isolated between 1991 and 1995 and 18 between 2000 
and 2003. These different RFLP patterns can be used to distinguish unequivocally between Spanish field strains of 
PRRSV and the three MLV type-I vaccines used in Spain: AmervacPRRS®, Pyrsvac-183® and PorcilisPRRS®. 
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Resumen
Comunicación corta. Diferenciación de cepas vacunales del virus del síndrome reproductor y respiratorio porcino 
de tipo I y cepas de campo por análisis de polimorfismos en la longitud de fragmentos de restricción
Para controlar la infección por el virus del síndrome reproductor y respiratorio porcino (PRRSV), en la gran mayo-
ría de países de América, Asia y Europa, incluyendo España, se usan frecuentemente vacunas basadas en virus vivos 
modificados (MLV). En la actualidad existen técnicas discriminatorias que permiten detectar cepas vacunales del 
PRRSV de tipo II. El presente trabajo describe una técnica precisa y rápida para la diferenciación de cepas vacunales 
de tipo I del PRRSV y cepas de campo españolas. Esta técnica se basa en la transcripción reversa y posterior amplifi-
cación de la ORF5 del genoma del PRRSV utilizando la reacción en cadena de la polimerasa anidada, seguida de la 
digestión de los amplicones generados con dos endonucleasas específicas: ItaI y AccI. La utilización combinada de 
ambas enzimas genera patrones de polimorfismos en la longitud de fragmentos de restricción (RFLP), adecuados para 
la distinción de las 30 cepas de campo usadas, de las cuales 12 fueron aisladas entre 1991 y 1995 y 18 entre 2000 y 
2003. Estos diferentes patrones pueden ser utilizados para distinguir entre cepas de campo españolas del PRRSV y las 
tres cepas vacunales de tipo I usadas en España: AmervacPRRS®, Pyrsvac-183® y PorcilisPRRS®. 
Palabras clave adicionales: epidemiología; España; Europa; heterogeneidad; PRRSV; RFLP; variabilidad ge-
nómica.
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To validate the technique, RFLP patterns of 
30 Spanish PRRSV isolates were compared to those 
of the three MLV type-I vaccines (AmervacPRRS®, 
Pyrsvac-183® and PorcilisPRRS®). For this purpose, 
RNA was extracted using Chelex® 100 resin (BioRad, 
Hercules, CA, USA) as described Walsh et al. (1991). 
The RT-PCR was performed using a commercial one-
step RT-PCR kit (GeneAmp® Gold RNA PCR Core 
kit, Applied Biosystems, Foster City, CA, USA), fol-
lowing the manufacturer´s instructions. Primers used 
to amplify the whole ORF5 and the flanking regions 
of ORF4 and ORF6 were previously reported by Pri-
eto et al. (2009). Second round PCR amplification was 
performed following a preceding technique (Suárez 
et al., 1994). An amplicon of 606 bp than comprises 
the whole ORF5 was obtained. The restriction enzyme 
ItaI (Roche, Basel, Switzerland) was used to digest 
the products of the second round PCR. For this pur-
pose, 14 µL of each PCR product were incubated at 37ºC 
overnight in a digestion mixture containing 3 U of the 
enzyme and 2 µL of the corresponding buffer in a final 
volume of 20 µL. The products of digestion were 
visualized by electrophoresis at 50 V for 3 hours in 
3% agarose gels (AG5, Ecogen, Spain) prepared in 
TBE 1x. Quantity One BioRad software version 4.2.1. 
(BioRad, Hercules, CA, USA) was used to predict the 
size of the bands on agarose gels.When RFLP patterns 
obtained after digestion with ItaI were the same for 
field isolates and one of the MLV vaccine strains used 
—PorcilisPRRS®—, a second digestion with the re-
striction enzyme AccI (Roche, Basel, Switzerland) was 
performed in the above mentioned conditions.
The restriction enzyme ItaI cut ORF5 of all strains 
tested, including field and vaccine strains, at least 
once (Fig. 1a and 1b). A total of 18 different RFLP 
patterns were obtained. Some of them were very alike 
—i.e. patterns 2, 9 and 11. Of the 18 patterns found, 
pattern 1 corresponded to two Spanish MLV vaccines 
—AmervacPRRS® and Pyrsvac-183®—, pattern 2 
corresponded to PorcilisPRRS® vaccine strain, and 
the sixteen additional RFLP patterns corresponded to 
the Spanish field PRRSV strains. The number of RFLP 
patterns obtained for recently isolated field viruses 
(Fig. 1a) —15 patterns in 18 strains tested— is high-
er than the number of RFLP patterns for isolates ob-
tained in the first few years after the description of 
the disease (Fig. 1b) —6 in 12 strains tested—.
Comparison of RFLP patterns obtained by digestion 
of vaccine strains and field isolates with ItaI shows that 
most of the field isolates tested exhibited RFLP patterns 
Porcine reproductive and respiratory syndrome (PRRS) 
is one of the most relevant swine diseases, characterized 
by reproductive failure in sows and respiratory distress in 
pigs of all ages (Rossow, 1998). The causative agent, 
PRRS virus (PRRSV), is a small, enveloped RNA virus 
classified within the Arteriviridae family (Cavanagh, 
1997) which is divided into type-I and type-II based on 
the high genetic, antigenic and pathogenic heterogeneity 
among different viral isolates (Meng, 2000).
The diagnosis of PRRSV infection is frequently based 
on the detection of a portion of PRRSV genome by re-
verse transcription polymerase chain reaction (RT-PCR) 
in clinical samples (Suárez et al., 1994; Christopher-
Henning et al., 1995). The extensive use of modified live 
virus (MLV) vaccines for the control of PRRS, both in 
growing and breeding pigs, might hinder the diagnosis of 
the disease. Furthermore, all available MLV vaccines 
based either on type-I or type-II strains induce a long-
lasting viremia in vaccinated pigs similar to that produced 
by field viruses (Mengeling et al., 1999; Scortti et al., 
2006). Therefore, a rapid, sensitive and accurate technique 
that allows the discrimination between vaccine and field 
strains of PRRSV is necessary. In those lines, a test based 
on the patterns produced by digestion of PCR products 
with different restriction enzymes has been developed for 
the differentiation of type-II field strains and Ingelvac 
PRRS MLV/Repro™, a MLV type-II vaccine frequently 
used for the control of the disease (Wesley et al., 1998). 
This method has frequently been used to typify PRRSV 
type-II isolates (Cai et al., 2002; Brar et al., 2011). None-
theless, the extensive genetic differences between type-I 
and type-II strains of PRRSV make the application of this 
technique useless in the European situation. 
The present study describes an easy and fast technique 
that discriminates MLV type-I vaccine strains from field 
strains, by means of RT and nested polymerase chain 
reaction (nPCR) amplification of PRRSV ORF5 and 
restriction fragment length polymorphisms (RFLP) 
analysis of RT-nPCR products digested with specific 
endonucleases. To determine which restriction enzymes 
would differentiate MLV type-I vaccine strains from field 
strains, PRRSV type-I ORF5 sequences were obtained 
from nucleotide data bases (EMBL/GenBank libraries) 
and restriction patterns for different enzymes examined 
using WebCutter 2.0 software (http://rna.lundberg.gu.se/
cutter2). ItaI was selected on the basis of predicted 
cutting patterns. Later on, a second restriction enzyme 
—AccI— was chosen to determine a second RFLP pat-
tern for a particular group of strains that shared the same 
RFLP pattern than one of the MLV type-I vaccine.
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distinguishable from vaccine strains. However, one field 
isolate exhibited RFLP pattern 1 while three of them 
showed RFLP pattern 2. The only isolate that exhibited 
the same RFLP pattern than the Spanish vaccine strains 
(pattern 1) was isolated from a herd that has started vac-
cination with a MLV Spanish vaccine a few months 
earlier. To study whether this isolate had a vaccine ori-
gin, the PCR product of ORF5 was sequenced and 
compared to ORF5 of the Spanish vaccine strain used 
in the farm. A percentage of similarity of 99.5% seems 
to confirm that this isolate derivates from the vaccine 
strain used in the farm (Fig. 2). A similar result has been 
previously reported between Porcilis PRRS® strain and 
field isolates showing close phylogenetic relationships 
(Pesente et al., 2006). However, the digestion of RT-PCR 
products of isolates that shared the RFLP pattern 2 when 
cut with ItaI with a second restriction enzyme, AccI, 
rendered different patterns indicating that those field 
isolates are different from the vaccine strain. Accord-
ingly, pattern 1 corresponded to the vaccine strain while 
pattern 2 was shared by two recent field isolates and 
pattern 3 was found in one early isolate (Fig. 1c).
The study of RFLP patterns of field PRRSV isolates 
could be a first approach to discard the vaccine origin 
of a strain implicated in an outbreak of the disease. The 
usefulness of this approach has been confirmed for type-
II strains using 3 different restriction enzymes (Wesley 
et al., 1998). The present study confirms that an analo-
gous technique can be applied to type-I strains. Thus, 
the digestion of PCR products of PRRSV type-I ORF5 
with only one or, occasionally, two restriction enzymes 
(ItaI and AccI), differentiates efficiently vaccines and 
field strains. Increasing the number of strains with rep-
resentatives of different countries would confirm the 
usefulness of this technique in epidemiologic studies. 
Furthermore, the fact that the number of RFLP patterns 
found in isolates of recent years is higher than in those 
from early years, after the description of the disease, 
indicates a continuous genetic drift that increases ge-
netic diversity. This scenario has been previously docu-
mented (Wesley et al., 1999; Prieto et al., 2009).
In conclusion, RFLP analyses of PRRSV type-I 
isolates can be considered an useful, fast and conven-
ient method to discriminate between field and vaccine 
Figure 1. Restriction fragment length polymorphism (RFLP) patterns obtained after digestion with ItaI of vaccine strains and Span-
ish PRRSV strains isolated between 2000 and 2003 (1a) or between 1991 and 1995 (1b). RFLP patterns obtained after digestion 
with AccI of PorcilisPRRS® and field isolates that showed RFLP pattern 2 after cut with ItaI (1c). The numbers indicate the differ-
ent patterns obtained for these PRRSV strains. The total number of RFLP patterns was 15 for strains isolated between 2000 and 
2003 and 6 for strains isolated between 1991 and 1995. The first patterns correspond to vaccine strains, AmervacPRRS®, Pyrs-































































































































































77Differentiation of type-I PRRSV vaccines and field strains by RFLP
viruses, although additional studies comprising more 
isolates should be performed to give strength to the 
technique. Additionally, the study of RFLP patterns 
could be useful in epidemiological studies, although a 
thoughtful study should include sequencing approach-
es to characterize unequivocally every PRRSV strain.
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Figure 2. Comparison of the sequences of AmervacPRRS® 
ORF5 (above) and PRRSV-16 ORF5 (below), respectively. The 
99.5% sequence similarity would confirm that the field isolate 
PRRSV-16 derivates from the vaccine strain used a few months 
earlier for the vaccination of the same herd. 
